Schedule 13G ownership disclosure

THERAPIX BIOSCIENCES LTD

Security class unavailable · CUSIP: 88339A203

Event date: 2022-03-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001575872-22-000386
Form type
SC 13G/A
Filer
EIDE ROBERT J
CIK
CIK 1181955
Filed
May 09, 2022
Reporting period
Mar 25, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub